What's A Biologic Revolution? With Vaxxinity's Mei Mei Hu, J.D.

Vaxxinity CEO Mei Mei Hu, J.D. leads a company with some lofty ambitions. The democratization of healthcare, interplanetary colonization, and development of accessible therapeutic vaccines to serve and enable both. Those big-picture visions have helped the company establish itself as a pioneer of the "third biologics revolution." On this week's Business of Biotech podcast, Mei Mei joins me to share Vaxxinity's strategy, what "democratization" and "revolution" really_mean, why traditional vaccines and biologic therapies are converging to form the "third biologic revolution," and a whole lot more.